Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Winearls

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1Denise Walker, Mark Consugar, Jeff Slezak, et al.
Kidney International|April 23, 2002
A complete mutation screen of the ADPKD genes by DHPLCSandro Rossetti, Dominique Chauveau, Denise Walker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2010
Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanomaWilliam G Herrington, Denis C Talbot, Michael M Lahn, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2011
An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND studyJan-Christoph Galle, Kathleen Claes, Istvan Kiss, et al.
Kidney International|February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapyBenjamin C Storey, Natalie Staplin, Charlie H Harper, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2012
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencingSandro Rossetti, Katharina Hopp, Robert A Sikkink, et al.
The Lancet. Haematology|March 16, 2019
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trialColin A Hutchison, Paul Cockwell, Veronica Moroz, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal diseaseSandro Rossetti, Sarah Burton, Lana Strmecki, et al.
The New England Journal of Medicine|October 27, 2018
Intravenous Iron in Patients Undergoing Maintenance HemodialysisIain C Macdougall, Claire White, Stefan D Anker, et al.
Journal of the American Society of Nephrology : JASN|May 4, 2017
Biliary Tract and Liver Complications in Polycystic Kidney DiseaseParminder K Judge, Charlie H S Harper, Benjamin C Storey, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1Denise Walker, Mark Consugar, Jeff Slezak, et al.
Kidney International|April 23, 2002
A complete mutation screen of the ADPKD genes by DHPLCSandro Rossetti, Dominique Chauveau, Denise Walker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2010
Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanomaWilliam G Herrington, Denis C Talbot, Michael M Lahn, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2011
An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND studyJan-Christoph Galle, Kathleen Claes, Istvan Kiss, et al.
Kidney International|February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapyBenjamin C Storey, Natalie Staplin, Charlie H Harper, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2012
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencingSandro Rossetti, Katharina Hopp, Robert A Sikkink, et al.
The Lancet. Haematology|March 16, 2019
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trialColin A Hutchison, Paul Cockwell, Veronica Moroz, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal diseaseSandro Rossetti, Sarah Burton, Lana Strmecki, et al.
The New England Journal of Medicine|October 27, 2018
Intravenous Iron in Patients Undergoing Maintenance HemodialysisIain C Macdougall, Claire White, Stefan D Anker, et al.
Journal of the American Society of Nephrology : JASN|May 4, 2017
Biliary Tract and Liver Complications in Polycystic Kidney DiseaseParminder K Judge, Charlie H S Harper, Benjamin C Storey, et al.
Pageof 3